ADC deployed $1.55B in 2025 across 338 retail net lease properties, strengthening investment-grade rent and setting up $1.25B ...
Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical evaluationCompelling anti-inflammatory activity of G1090N was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback